Related Experiment Videos
Acral (volar-subungual) melanoma.
The British Journal of Surgery
|August 1, 1985
Summary
Acral melanoma, a distinct skin cancer subtype, often presents late, leading to delayed diagnosis and treatment. Early detection is crucial for improving outcomes in this challenging cancer.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Acral melanoma is a distinct malignant melanoma subtype.
- It occurs on the volar surfaces of extremities and subungual areas.
- Characterized by unique clinical and pathological features.
Purpose of the Study:
- To analyze the clinical characteristics, treatment, and outcomes of acral melanoma.
- To highlight the challenges in diagnosing acral melanoma.
- To evaluate the efficacy of various treatment modalities.
Main Methods:
- Retrospective analysis of 340 malignant melanoma patients.
- Inclusion of 24 patients diagnosed with acral melanoma.
- Review of clinical presentation, histological findings, staging, treatment, and patient outcomes.
Main Results:
- Acral melanoma constituted 7% of malignant melanoma cases.
- Diagnosis delay ranged from 6 months to 5 years, with most presenting as advanced tumors.
- Acral lentiginous melanoma histology was observed in 14 cases.
- 14 patients were stage I, 7 stage II, and 3 stage III at diagnosis.
- Surgical excision was the primary treatment; amputation and lymph node dissection were performed.
- Regional metastases were found in 9 of 14 patients undergoing lymph node dissection.
- 14 patients died from metastatic disease within 1-5 years; 4 have metastatic spread; 6 are disease-free.
Conclusions:
- Acral melanoma presents unique diagnostic and therapeutic challenges.
- Delayed diagnosis significantly impacts prognosis.
- Multidisciplinary treatment approaches are essential for managing acral melanoma.
- Further research is needed to improve early detection and treatment strategies.